Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Consultation ARM 51 seeks your views on the reclassification of Cystobid 100 mg Capsules from prescription only medicine (POM) to pharmacy availability (P).
Comments should be sent by post to Veronica Popo in room 14-138, Market Towers, 1 Nine Elms Lane, London, SW8 5NQ or by e-mail (reclassification@mhra.gsi.gov.uk) to arrive by 14 April 2008.
Public consultation ARM 51: Request to reclassify Cystobid 100mg Capsules from prescription only medicine (POM) to pharmacy availability (P) 
